Marker Therapeutics, Inc.
MRKR
$1.03
-$0.075-6.82%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -48.50% | -56.96% | 76.89% | 28.26% | -3.33% |
Total Receivables | 793.64% | 42.61% | -11.11% | -57.21% | -95.04% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -39.55% | -33.68% | -62.24% | -46.57% | -27.62% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -44.01% | -46.82% | 29.13% | 3.06% | -13.10% |
|
|||||
Total Current Assets | -44.01% | -46.82% | 29.13% | 3.06% | -13.10% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -44.01% | -46.82% | -49.57% | -50.24% | -52.60% |
|
|||||
Total Accounts Payable | 63.43% | -18.65% | -58.03% | -12.72% | -42.36% |
Total Accrued Expenses | 13.74% | -65.20% | -60.54% | 50.53% | -65.21% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -52.11% | 8.62% | 88.81% | -96.21% | -92.07% |
Total Other Current Liabilities | -52.11% | 8.62% | 88.81% | -96.21% | -92.07% |
Total Current Liabilities | 24.51% | -32.48% | -55.73% | -60.49% | -75.37% |
|
|||||
Total Current Liabilities | 24.51% | -32.48% | -55.73% | -60.49% | -75.37% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 24.51% | -32.48% | -80.85% | -79.25% | -84.99% |
|
|||||
Common Stock & APIC | 0.10% | 0.23% | 0.34% | 0.60% | 0.76% |
Retained Earnings | -2.24% | -2.41% | -1.31% | -1.92% | -2.19% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -55.41% | -49.03% | -25.92% | -28.31% | -26.08% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -55.41% | -49.03% | -25.92% | -28.31% | -26.08% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -55.41% | -49.03% | -25.92% | -28.31% | -26.08% |
|